Re: 2023 Outlook per MD&A
|
2
|
Resverlogix Corp.
|
Apr 09, 2023 07:20AM
|
Re: Annual and Special Meeting
|
3
|
Resverlogix Corp.
|
Apr 08, 2023 06:43AM
|
Annual and Special Meeting
|
1
|
Resverlogix Corp.
|
Apr 06, 2023 10:17AM
|
Re: Highest Volume days in last Five Years
|
1
|
Resverlogix Corp.
|
Apr 05, 2023 10:48AM
|
Re: Hump Day Fun
|
1
|
Resverlogix Corp.
|
Apr 03, 2023 11:54AM
|
Re: debenture
|
1
|
Resverlogix Corp.
|
Mar 20, 2023 01:00PM
|
Re: New paper
|
4
|
Resverlogix Corp.
|
Mar 19, 2023 04:03PM
|
Re: Another Report of Exempt Distribution
|
2
|
Resverlogix Corp.
|
Mar 18, 2023 11:59AM
|
Another Report of Exempt Distribution
|
2
|
Resverlogix Corp.
|
Mar 18, 2023 11:44AM
|
Additional Reports of Exempt Distribution
|
3
|
Zenith Epigenetics
|
Mar 18, 2023 11:39AM
|
Re: TD Ameritrade
|
1
|
Zenith Epigenetics
|
Mar 14, 2023 03:54PM
|
Re: Halted
|
1
|
Zenith Epigenetics
|
Mar 09, 2023 05:10PM
|
Re: Halted
|
1
|
Zenith Epigenetics
|
Mar 09, 2023 01:47PM
|
What Is Peritoneal Carcinomatosis?
|
1
|
Zenith Epigenetics
|
Mar 09, 2023 12:51PM
|
Re: Halted
|
|
Zenith Epigenetics
|
Mar 09, 2023 12:14PM
|
Re: BARCHART OPINION - Overall Average 100% BUY
|
|
Zenith Epigenetics
|
Mar 08, 2023 05:20AM
|
Re: CALGARY, Alberta, March 02, 2023 - Resverlogix Corp.
|
2
|
Resverlogix Corp.
|
Mar 05, 2023 09:10AM
|
CALGARY, Alberta, March 02, 2023 - Resverlogix Corp.
|
5
|
Resverlogix Corp.
|
Mar 02, 2023 03:08PM
|
Re: New Publication Conclusion
|
3
|
Resverlogix Corp.
|
Mar 02, 2023 10:22AM
|
Re: New Publication Conclusion
|
3
|
Resverlogix Corp.
|
Mar 01, 2023 01:13PM
|